FOS - Fos proto-oncogene, AP-1 transcription factor subunit Gene
Species: Canis lupus familiaris (sub-species: familiaris)
Gene Type: protein coding
Gene ID: 490792
FOS Products (1)
| mRNA | Protein | Name |
|---|---|---|
| XM_038672975.1 | XP_038528903.1 | proto-oncogene c-Fos |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
proto-oncogene c-Fos |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-113756A | Latanoprost acid | Agonist | 98.77% | Unkown |
| HY-B1052A | Lofexidine | Agonist | 99.08% | Unkown |
| HY-B1052 | Lofexidine hydrochloride | Agonist | 99.72% | Unkown |
| HY-A0116A | Trandolaprilate hydrate | Inhibitor | 97.30% | Unkown |
| HY-A0116 | Trandolaprilate | Inhibitor | 99.42% | Unkown |
| HY-B1052R | Lofexidine hydrochloride (Standard) | Agonist | / | Unkown |
Clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-12270 | T-5224 | Inhibitor | 99.59% | Phase 2 |
| HY-100426A | Osemozotan hydrochloride | Agonist | / | Phase 2 |
| HY-113726 | Nerisopam | Agonist | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(62)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P10408 | Candidalysin | Activator | 99.81% | Unkown |
| HY-N0231 | Bavachalcone | 99.90% | Unkown | |
| HY-N2119 | Sciadopitysin | Inhibitor | 99.0% | Unkown |
| HY-N6837 | Fructo-oligosaccharide DP7/GF6 | 99.94% | Unkown | |
| HY-P10927 | BRP | 99.62% | Unkown | |
| HY-N5048 | Galloylpaeoniflorin | Inhibitor | 98.30% | Unkown |
| HY-N0805A | Alisol B | 99.57% | Unkown | |
| HY-165126 | Schizophyllan | / | Unkown | |
| HY-A0299 | H-Gly-Pro-Hyp-OH | Inhibitor | 99.52% | Unkown |
| HY-P3261 | Inulinase | / | Unkown | |
| HY-P10506 | CMX-8933 | Activator | 99.77% | Unkown |
| HY-107621 | U0124 | 98.0% | Unkown | |
| HY-169021 | JNK-1-IN-3 | Inhibitor | 98.44% | Unkown |
| HY-59201A | A-582941 dihydrochloride | 99.78% | Unkown | |
| HY-182757 | Y1693 | Inhibitor | 99.91% | Unkown |
| HY-N6836 | Fructo-oligosaccharide DP8/GF7 | 99.76% | Unkown | |
| HY-124277 | ADM 12 | Antagonist | 98.86% | Unkown |
| HY-P10927A | BRP TFA | / | Unkown | |
| HY-B1052S | Lofexidine-d4 hydrochloride | Agonist | / | Unkown |
| HY-100839 | (RS)-(Tetrazol-5-yl)glycine | Agonist | 96.53% | Unkown |
| HY-106584 | Mosapramine | Antagonist | 98.58% | Unkown |
| HY-114753 | Neboglamine | Modulator | / | Unkown |
| HY-168895 | c-Fos-IN-1 | 97.24% | Unkown | |
| HY-N6835 | Fructo-oligosaccharide DP9/GF8 | 99.83% | Unkown | |
| HY-P10405A | TAT-D1 peptide acetate | Inhibitor | / | Unkown |
| HY-RS05032 | FOS Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS16815 | Fos Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-106153B | E-5842 citrate | Ligand | / | Unkown |
| HY-107614G | 1-Oleoyl lysophosphatidic acid sodium (GMP) | Activator | / | Unkown |
| HY-113443 | 12(S)-HPETE | Activator | / | Unkown |
| HY-113756B | rel-Latanoprost acid | Agonist | / | Unkown |
| HY-116640 | Amorphigenin | Inhibitor | / | Unkown |
| HY-120306 | HHL-6 | Inhibitor | / | Unkown |
| HY-12270S | T-5224-d8 | / | Unkown | |
| HY-131721 | 14,15-EET-SI | Activator | / | Unkown |
| HY-15026 | ATB 429 | / | Unkown | |
| HY-168482 | NF-κB/MAPK-IN-2 | Inhibitor | / | Unkown |
| HY-168895A | (E,E)-c-Fos-IN-1 | / | Unkown | |
| HY-169451 | Cannabidiolic acid methyl ester | Modulator | / | Unkown |
| HY-175007 | RIPK1-IN-32 | Inhibitor | / | Unkown |
| HY-176019 | Methylcarbamyl PAF C-8 | / | Unkown | |
| HY-179216 | KTT-1 | Inhibitor | / | Unkown |
| HY-179684 | PCC0105005 | / | Unkown | |
| HY-182504 | NRA-0562 | / | Unkown | |
| HY-59201 | A-582941 | / | Unkown | |
| HY-A0116S1 | Trandolaprilate-d6 | / | Unkown | |
| HY-B1052S1 | Lofexidine-d4 | Agonist | / | Unkown |
| HY-E70684 | CDK5/p25NCK Recombinant Human Active Protein Kinase | / | Unkown | |
| HY-E70685 | CDK5/p35NCK Recombinant Human Active Protein Kinase | / | Unkown | |
| HY-N10076 | Ganomycin I | Inhibitor | / | Unkown |
| HY-N11775 | Eudebeiolide B | / | Unkown | |
| HY-N1326 | Santamarine | 98.85% | Unkown | |
| HY-N18209 | 4-Hydroxy-3-butylphthalide | / | Unkown | |
| HY-N3071 | Picrasidine I | / | Unkown | |
| HY-N6834 | Fructo-oligosaccharide DP10/GF9 | 98.0% | Unkown | |
| HY-P11617 | CLP-d2 | Inhibitor | / | Unkown |
| HY-174682 | Human FOS mRNA | / | Unkown | |
| HY-B1606 | Chlorothymol | 99.70% | Unkown | |
| HY-N7008 | Fructo-oligosaccharide DP11/GF10 | 98.57% | Unkown | |
| HY-N7009 | Fructo-oligosaccharide DP12/GF11 | 98.0% | Unkown | |
| HY-P10405 | TAT-D1 peptide | Antagonist | / | Unkown |
| HY-RS23255 | Fos Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |